OBJECTIVE: Biomarkers are needed to improve the sensitivity and accuracy of diagnosis, and also prognosis, in individuals with early Alzheimer disease (AD). Measures of brain structure and disease-related proteins in the cerebrospinal fluid (CSF) have been proposed as biomarkers, yet relatively little is known about the relationships between such measures. The present study was conducted to assess the relationship between CSF Aβ and tau protein levels and longitudinal measures of hippocampal structure in individuals with and without very mild dementia of the Alzheimer type. DESIGN: A single CSF sample and longitudinal magnetic resonance scans were collected. The CSF samples were assayed for tau, phosphorylated tau181 (p-tau181), Aβ1-42, and Aβ1-40 using an enzyme-linked immunosorbent assay. Large-deformation diffeomorphic metric mapping was used to generate hippocampal surfaces, and a composite hippocampal surface (previously constructed from 86 healthy participants) was used as a structural reference. PATIENTS OR OTHER PARTICIPANTS: Thirteen participants with very mild AD (Clinical Dementia Rating, CDR 0.5) and 11 cognitively normal participants (CDR 0). INTERVENTION: None. MAIN OUTCOME MEASURES: Initial and rate-of-change measures of total hippocampal volume and displacement of the hippocampal surface within zones overlying the CA1, subiculum, and CA2-4+DG cellular subfields, and their correlations with initial CSF measures. RESULTS: Lower CSF Αβ1-42 levels and higher tau/Αβ1-42 and p-tau181/Αβ1-42 ratios were strongly correlated with decreases in hippocampal volume and measures of progressive inward deformations of the CA1 subfield in participants with early AD, but not in cognitively normal participants. CONCLUSIONS: Despite the small sample size, we found that Αβ1-42 related and tau-related CSF measures were associated with hippocampal degeneration in individuals with clinically diagnosed early AD and may reflect an association with a common underlying disease mechanism.
OBJECTIVE: Biomarkers are needed to improve the sensitivity and accuracy of diagnosis, and also prognosis, in individuals with early Alzheimer disease (AD). Measures of brain structure and disease-related proteins in the cerebrospinal fluid (CSF) have been proposed as biomarkers, yet relatively little is known about the relationships between such measures. The present study was conducted to assess the relationship between CSF Aβ and tau protein levels and longitudinal measures of hippocampal structure in individuals with and without very mild dementia of the Alzheimer type. DESIGN: A single CSF sample and longitudinal magnetic resonance scans were collected. The CSF samples were assayed for tau, phosphorylated tau181 (p-tau181), Aβ1-42, and Aβ1-40 using an enzyme-linked immunosorbent assay. Large-deformation diffeomorphic metric mapping was used to generate hippocampal surfaces, and a composite hippocampal surface (previously constructed from 86 healthy participants) was used as a structural reference. PATIENTS OR OTHER PARTICIPANTS: Thirteen participants with very mild AD (Clinical Dementia Rating, CDR 0.5) and 11 cognitively normal participants (CDR 0). INTERVENTION: None. MAIN OUTCOME MEASURES: Initial and rate-of-change measures of total hippocampal volume and displacement of the hippocampal surface within zones overlying the CA1, subiculum, and CA2-4+DG cellular subfields, and their correlations with initial CSF measures. RESULTS: Lower CSF Αβ1-42 levels and higher tau/Αβ1-42 and p-tau181/Αβ1-42 ratios were strongly correlated with decreases in hippocampal volume and measures of progressive inward deformations of the CA1 subfield in participants with early AD, but not in cognitively normal participants. CONCLUSIONS: Despite the small sample size, we found that Αβ1-42 related and tau-related CSF measures were associated with hippocampal degeneration in individuals with clinically diagnosed early AD and may reflect an association with a common underlying disease mechanism.
Authors: Ira Driscoll; Yun Zhou; Yang An; Jitka Sojkova; Christos Davatzikos; Michael A Kraut; Weiguo Ye; Luigi Ferrucci; Chester A Mathis; William E Klunk; Dean F Wong; Susan M Resnick Journal: Neurobiol Aging Date: 2010-02-21 Impact factor: 4.673
Authors: C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E G Tangalos; E Kokmen Journal: Neurology Date: 2000-08-22 Impact factor: 9.910
Authors: Randy L Buckner; Denise Head; Jamie Parker; Anthony F Fotenos; Daniel Marcus; John C Morris; Abraham Z Snyder Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: Lei Wang; Jeffrey S Swank; Irena E Glick; Mokhtar H Gado; Michael I Miller; John C Morris; John G Csernansky Journal: Neuroimage Date: 2003-10 Impact factor: 6.556
Authors: John R Cirrito; Patrick C May; Mark A O'Dell; Jennie W Taylor; Maia Parsadanian; Jeffrey W Cramer; James E Audia; Jeffrey S Nissen; Kelly R Bales; Steven M Paul; Ronald B DeMattos; David M Holtzman Journal: J Neurosci Date: 2003-10-01 Impact factor: 6.167
Authors: Christine L Tardif; Gabriel A Devenyi; Robert S C Amaral; Sandra Pelleieux; Judes Poirier; Pedro Rosa-Neto; John Breitner; M Mallar Chakravarty Journal: Hum Brain Mapp Date: 2017-11-21 Impact factor: 5.038
Authors: Craig Ritchie; Nadja Smailagic; Anna H Noel-Storr; Obioha Ukoumunne; Emma C Ladds; Steven Martin Journal: Cochrane Database Syst Rev Date: 2017-03-22
Authors: Mark R Libowitz; Ke Wei; Thao Tran; Karen Chu; Kristina Moncrieffe; Michael G Harrington; Kevin King Journal: PLoS One Date: 2021-07-22 Impact factor: 3.240
Authors: L E M Wisse; S Ravikumar; R Ittyerah; S Lim; J Lane; M L Bedard; L Xie; S R Das; T Schuck; M Grossman; E B Lee; M D Tisdall; K Prabhakaran; J A Detre; G Mizsei; J Q Trojanowski; E Artacho-Pérula; M M de Iñiguez de Onzono Martin; M M Arroyo-Jiménez; M Muñoz Lopez; F J Molina Romero; M P Marcos Rabal; S Cebada Sánchez; J C Delgado González; C de la Rosa Prieto; M Córcoles Parada; D A Wolk; D J Irwin; R Insausti; P A Yushkevich Journal: Acta Neuropathol Commun Date: 2021-07-21 Impact factor: 7.801
Authors: Michael G Harrington; Jiarong Chiang; Janice M Pogoda; Megan Gomez; Kris Thomas; Sarah Deboard Marion; Karen J Miller; Prabha Siddarth; Xinyao Yi; Feimeng Zhou; Sherri Lee; Xianghong Arakaki; Robert P Cowan; Thao Tran; Cherise Charleswell; Brian D Ross; Alfred N Fonteh Journal: PLoS One Date: 2013-11-18 Impact factor: 3.240
Authors: Lei Wang; Ashley Heywood; Jane Stocks; Jinhyeong Bae; Da Ma; Karteek Popuri; Arthur W Toga; Kejal Kantarci; Laurent Younes; Ian R Mackenzie; Fengqing Zhang; Mirza Faisal Beg; Howard Rosen Journal: J Psychiatr Brain Sci Date: 2019-10-30